BRISTOL-MYERS SQUIBB COMPANY for BRISTOL-MYERS SQUIBB COMPANY
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report | Jul 20, 2015 | $670,000 | Replaced |
| 2nd Quarter - Amendment (this page) | Nov 29, 2016 | $670,000 | Yes |
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
S. Con. Res. 11, budget resolution, regarding all biopharmaceutical related provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LANE PENRY | — |
| CHRISTOPHER PERNIE | — |
| PAUL ANTHONY WILLIAMS | — |
Trade (domestic/foreign) TRD
No bill, lobbied to strengthen intellectual property rights in trade agreements and international negotiations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LANE PENRY | — |
| CHRISTOPHER PERNIE | — |
| PAUL ANTHONY WILLIAMS | — |
Copyright/Patent/Trademark CPT
HR 9, the Innovation Act, regarding all biopharmaceutical related provisions. S. 1137, Protecting American Talent and Entrepreneurship Act, regarding all biopharmaceutical related provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LANE PENRY | — |
| CHRISTOPHER PERNIE | — |
| PAUL ANTHONY WILLIAMS | — |
Health Issues HCR
Labor, HHS Appropriations,regarding all biopharmaceutical related provisions. Agriculture Appropriations, regarding all biopharmaceutical related provisions. H.R. 1078, FDA Safety Over Sequestration Act, regarding all biopharmaceutical related provisions. No bill, raised awareness about atrial fibrillation and stroke prevention. H/R. 1101, Viral Hepatitis Testing Act, regarding all biopharmaceutical related provisions. H.R.6, 21st Century Cures Initiative, regarding all biopharmaceutical related provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RONALD MILLER | — |
| LANE PENRY | — |
| CHRISTOPHER PERNIE | — |
| PAUL ANTHONY WILLIAMS | — |
Medicare/Medicaid MMM
H.R. 1416, Cancer Patient Protection Act, regarding all biopharmaceutical related provisions. H.R. 1190 and S. 41, Protecting Seniors' Access to Medicare Act, regarding all biopharmaceutical related provisions. H.R. 2, Medicare Access and CHIP Authorization Act, regarding all biopharmaceutical related provisions H.R. 2570, Strengthening Medicare Advantage through Innovation and Transparency for Seniors Act, regarding all biopharmaceutical related provisions.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LANE PENRY | — |
| CHRISTOPHER PERNIE | — |
| PAUL ANTHONY WILLIAMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.